结直肠癌中小分子对自途径的表观遗传调节:系统性审查
Mozhdeh Zamani1,2, Farima Safari1, Morvarid Siri1
1Autophagy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Journal of cancer research and clinical oncology
|October 23, 2024
概括
针对表观遗传和自的小分子对结直肠癌 (CRC) 细胞死亡产生各种影响. 了解这些相互作用是通过调节自途径来开发新的CRC疗法的关键.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 结肠直肠癌 (CRC) 构成了全球严重的健康负担.
- 药物耐药性限制了当前CRC治疗的有效性.
- 针对表观遗传和自途径的小分子提供了潜在的治疗途径.
研究的目的:
- 系统地审查小分子对结肠直肠癌自的表观遗传影响.
- 根据这些相互作用,确定基于CRC的新型治疗策略.
主要方法:
- 按照PRISMA指南进行系统审查.
- 在PubMed,Scopus和Web of Science数据库中进行了搜索.
- 包括到2023年8月13日发表的研究.
主要成果:
- 包括8项研究,重点研究影响CRC自的表观遗传调节剂 (基因素乙化/脱乙化,DNA甲基化/脱甲基化,miRNA调节).
- 小分子表现出对自的多种影响,影响CRC细胞死亡 (例如,促进泛比诺斯塔,抑制阿司匹林).
- 小分子对自的表观遗传调节具有复杂而多样化的抗癌效应.
结论:
- 了解小分子,表观遗传学和自之间的相互作用对于有针对性的CRC治疗至关重要.
- 自的双重作用需要仔细考虑小分子的管理,以获得最佳的癌细胞命运和药物反应.
- 识别表观遗传机制对于有效的CRC治疗策略至关重要.
相关概念视频
Autophagy
4.2K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.2K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Delivery Pathways to the Lysosome
6.2K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
6.2K
Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K


